Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco A Romero

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Hematology & Oncology|August 14, 2013
Epigenetic changes: a common theme in acute myelogenous leukemogenesisSoraya E Gutierrez, Francisco A Romero-Oliva
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 31, 2006
Safety of the intranasal toll-like receptor 4 agonist CRX-675 in allergic rhinitisThomas B Casale, Jean Kessler, Francisco A Romero
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 4, 2008
Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadineDouglas H Jones, Francisco A Romero, Thomas B Casale
IEEE Transactions on Cybernetics|October 30, 2015
Automated GPR Rebar Analysis for Robotic Bridge Deck EvaluationParneet Kaur, Kristin J Dana, Francisco A Romero, et al.
The Journal of Allergy and Clinical Immunology|November 22, 2007
Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitisThomas B Casale, Francisco A Romero, Egilius L H Spierings
Pediatrics|April 3, 2004
Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibodyPhilip E Silkoff, Francisco A Romero, Niroo Gupta, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 12, 2009
Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthmaVinay Mehta, Jeffrey R Stokes, Abdo Berro, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2009
Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of beta-adrenergic bronchodilators and corticosteroidsRobert G Townley, Pradeep R Gendapodi, Nidal Qutna, et al.
The Journal of Allergy and Clinical Immunology|December 27, 2011
The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptomsJeffrey R Stokes, Francisco A Romero, Richard J Allan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Hematology & Oncology|August 14, 2013
Epigenetic changes: a common theme in acute myelogenous leukemogenesisSoraya E Gutierrez, Francisco A Romero-Oliva
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 31, 2006
Safety of the intranasal toll-like receptor 4 agonist CRX-675 in allergic rhinitisThomas B Casale, Jean Kessler, Francisco A Romero
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 4, 2008
Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadineDouglas H Jones, Francisco A Romero, Thomas B Casale
IEEE Transactions on Cybernetics|October 30, 2015
Automated GPR Rebar Analysis for Robotic Bridge Deck EvaluationParneet Kaur, Kristin J Dana, Francisco A Romero, et al.
The Journal of Allergy and Clinical Immunology|November 22, 2007
Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitisThomas B Casale, Francisco A Romero, Egilius L H Spierings
Pediatrics|April 3, 2004
Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibodyPhilip E Silkoff, Francisco A Romero, Niroo Gupta, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 12, 2009
Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthmaVinay Mehta, Jeffrey R Stokes, Abdo Berro, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2009
Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of beta-adrenergic bronchodilators and corticosteroidsRobert G Townley, Pradeep R Gendapodi, Nidal Qutna, et al.
The Journal of Allergy and Clinical Immunology|December 27, 2011
The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptomsJeffrey R Stokes, Francisco A Romero, Richard J Allan, et al.
Pageof 1